Association between Pan-immune-inflammation value and in-hospital mortality in critically ill patients with Chronic obstructive pulmonary disease: An observational study - 02/07/25
, Anju Puri b, 1, Yi Chen a, Yan Liu a, Shuliang Guo aAbstract |
Objective |
This study aimed to examine the relationship between the pan-immune inflammation value (PIV) and mortality in critically ill patients with chronic obstructive pulmonary disease (COPD), highlighting its potential as a prognostic tool for this high-risk group.
Methods |
This retrospective cohort study utilized data from the MIMIC-IV 2.2 database. Participants were stratified into tertiles based on their PIV levels, with the primary endpoint being in-hospital mortality. Cox proportional hazards regression models were used to analyze the association between PIV and mortality, and Kaplan-Meier survival curves illustrated survival differences among PIV tertiles. Subgroup analyses and interaction tests ensured the robustness of the findings.
Results |
A total of 3259 critically ill COPD patients were included. The in-hospital and 90-day mortality rates were 15 % and 27.6 %, respectively. Multivariate analysis showed that higher PIV levels were significantly associated with increased in-hospital (HR: 1.08, 95 % CI: 1.02–1.14, P = 0.012) and 90-day mortality (HR: 1.16, 95 % CI: 1.11–1.21, P < 0.001). Patients in the highest tertile of PIV (T3) had a significantly higher risk of mortality compared to those in the lowest tertile (T1). The trend test across tertiles demonstrated a positive association between PIV and mortality risk in all models (P for trend <0.001). Subgroup analyses revealed no significant effect modification except for gender and liver disease.
Conclusion |
Elevated baseline PIV was independently associated with higher mortality risks in critically ill COPD patients, suggesting its potential as a simple, reliable, and cost-effective prognostic indicator for high-risk patients.
Le texte complet de cet article est disponible en PDF.Highlights |
• | This is the first and most extensive study assessing the link between PIV and mortality in critically ill COPD patients. |
• | •Elevated PIV is significantly associated with increased in-hospital and 90-day all-cause mortality in COPD patients. |
• | •The study utilizes the MIMIC-IV database, involving 3259 critically ill patients, ensuring clinical relevance and statistical power. |
• | •PIV is a cost-effective, simple biomarker derived from routine CBC tests, valuable for risk stratification in critically ill COPD patients. |
• | •Findings suggest PIV as a practical tool for improving clinical decision-making and patient outcomes in ICU settings. |
Keywords : Chronic obstructive pulmonary disease, Critically ill, Inflammation, MIMIC-IV database, Mortality, Pan-immune inflammation value
Plan
Vol 245
Article 108213- août 2025 Retour au numéro
Article précédent
- Ethnic variation in South East Asian patients with severe asthma: A first look at the Singapore Severe Asthma Registry (SSAR) and implications on clinical practice
- Tunn Ren Tay, Pee Hwee Pang, Mei Fong Liew, Pei Yee Tiew, Mon Hnin Tun, Tavleen Kaur Jaggi, Anna Lau, Hui Fang Lim, Genevieve Tan, Nicole Yu-Fang Sieow, Sanjay H. Chotirmall, Mariko Siyue Koh
- ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up
- Laura Pini, Marco Caminati, Matteo Maule, Diego Bagnasco, Bianca Beghè, Benedetta Bondi, Fulvio Braido, Paolo Cameli, Cristiano Caruso, Claudia Crimi, Yehia El Masri, Jordan Giordani, Gabriella Guarnieri, Manuela Latorre, Andrea Mastrototaro, Francesco Menzella, Claudio Micheletto, Alessandro Pini, Stefano Piras, Antonio Spanevello, Andrea Vianello, Dina Visca, Martina Zappa, Marco Zurlo, Pierluigi Paggiaro, Francesco Blasi, Giorgio Walter Canonica, Gianenrico Senna, Roberto Benoni, SANI study group
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?